In the first year of availability of the cholesterol lowering medications PCSK9 inhibitors, fewer than 1 in 3 adults initially prescribed one of these inhibitors actually received it, owing to a combination of out-of-pocket costs and lack of insurance approval, according to a study.
from Top Health News – ScienceDaily http://ift.tt/2xEN9d7
from Tumblr http://ift.tt/2xIAozW
No comments:
Post a Comment